Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diagnos Inc (ADK.VN)

Diagnos Inc (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 22,611
  • Shares Outstanding, K 76,649
  • Annual Sales, $ 486 K
  • Annual Income, $ -2,481 K
  • 60-Month Beta -0.31
  • Price/Sales 107.52
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ADK.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date 02/28/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Health Information Services

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.230 +26.09%
on 03/28/24
0.350 -17.14%
on 04/08/24
+0.050 (+20.83%)
since 03/25/24
3-Month
0.230 +26.09%
on 03/28/24
0.410 -29.27%
on 02/02/24
-0.035 (-10.77%)
since 01/25/24
52-Week
0.230 +26.09%
on 03/28/24
0.590 -50.85%
on 09/08/23
+0.020 (+7.41%)
since 04/25/23

Most Recent Stories

More News
DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance

BROSSARD, Quebec, June 23, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group

BROSSARD, Quebec, June 07, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening

BROSSARD, Quebec, May 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico

BROSSARD, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Announces Closing of Private Placement and New Marketing Director

BROSSARD, Quebec, March 28, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership

Innovative diabetic retina screening service resulting in earlier intervention, better care, and savings to the Canadian healthcare system....

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, March 01, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Successfully Completes ISO / MDSAP Audit

BROSSARD, Quebec, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS Provides Corporate Update for 2021 and Outlook for 2022

BROSSARD, Quebec, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.

BROSSARD, Quebec, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.290 (-1.69%)
DGNOF : 0.2133 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services....

See More

Key Turning Points

3rd Resistance Point 0.298
2nd Resistance Point 0.297
1st Resistance Point 0.293
Last Price 0.290
1st Support Level 0.288
2nd Support Level 0.287
3rd Support Level 0.283

See More

52-Week High 0.590
Fibonacci 61.8% 0.452
Fibonacci 50% 0.410
Fibonacci 38.2% 0.368
Last Price 0.290
52-Week Low 0.230

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar